Understanding Lab Tests for Hepatoblastoma

Written by Private MD Labs Medical Writing Team • Last Updated: September 8, 2025

Hepatoblastoma is a rare form of liver cancer that primarily affects infants and young children. While the definitive diagnosis of hepatoblastoma requires imaging studies and tissue biopsy, blood tests play an important supporting role in monitoring specific tumor biomarkers and assessing the body's response to this serious condition.

Recommended Test

IGF-2

This test measures insulin-like growth factor 2 levels in the blood. Hepatoblastoma has been associated with increased levels of IGF-2, a biomarker that can promote cell growth and proliferation, potentially leading to tumor development. Monitoring IGF-2 levels can provide valuable information about the presence and activity of this rare liver cancer.

HSA/FSA accepted HSA/FSA accepted
Google reviews 2907 reviews
$562

The Role of Blood Testing in Hepatoblastoma

Although there is no single blood test that can diagnose hepatoblastoma, laboratory testing is fundamental for detecting elevated levels of specific biomarkers associated with the tumor. These tests help healthcare providers monitor disease progression, evaluate treatment effectiveness, and assess overall health status during management of this pediatric liver cancer.

Understanding the Results

Elevated IGF-2 levels may indicate the presence of hepatoblastoma and can help healthcare providers track the tumor's behavior over time. However, these results must always be interpreted in conjunction with clinical symptoms, imaging studies, and other diagnostic findings by qualified medical professionals.

Important Considerations

The information here is for educational purposes only and is not a substitute for professional medical advice. Hepatoblastoma is a serious condition requiring immediate medical attention. Always consult with a pediatric oncologist or healthcare provider for proper diagnosis and treatment.

References